| 13.79 -0.07 (-0.51%) | 01-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 16.32 | 1-year : | 19.07 |
| Resists | First : | 13.97 | Second : | 16.32 |
| Pivot price | 12.75  |
|||
| Supports | First : | 12.43 |
Second : | 11.47 |
| MAs | MA(5) : | 13.61 |
MA(20) : | 12.62 |
| MA(100) : | 11.86 |
MA(250) : | 10.69 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 92.5 |
D(3) : | 89.6 |
| RSI | RSI(14): 73.1  |
|||
| 52-week | High : | 15.46 | Low : | 6.76 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VREX ] has closed below upper band by 17.6%. Bollinger Bands are 111.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 13.98 - 14.05 | 14.05 - 14.11 |
| Low: | 13.35 - 13.42 | 13.42 - 13.48 |
| Close: | 13.67 - 13.8 | 13.8 - 13.89 |
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Wed, 14 Jan 2026
VREX: Investments in India, photon counting, and cargo systems set up strong multi-year growth - TradingView — Track All Markets
Wed, 14 Jan 2026
Liquidity Mapping Around (VREX) Price Events - Stock Traders Daily
Tue, 13 Jan 2026
Are Options Traders Betting on a Big Move in Varex Imaging Stock? - Zacks Investment Research
Fri, 09 Jan 2026
Should Value Investors Buy VAREX IMAGING (VREX) Stock? - Nasdaq
Fri, 09 Jan 2026
Is Varex Imaging (NASDAQ:VREX) A Risky Investment? - simplywall.st
Tue, 06 Jan 2026
Varex to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 42 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 95.6 (%) |
| Shares Short | 921 (K) |
| Shares Short P.Month | 835 (K) |
| EPS | -1.71 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.34 |
| Profit Margin | -8.4 % |
| Operating Margin | 8.5 % |
| Return on Assets (ttm) | 3.5 % |
| Return on Equity (ttm) | -13.6 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 6.96 |
| Sales Per Share | 20.25 |
| EBITDA (p.s.) | 2.23 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 42 (M) |
| Levered Free Cash Flow | 40 (M) |
| PE Ratio | -8.12 |
| PEG Ratio | 0 |
| Price to Book value | 1.21 |
| Price to Sales | 0.68 |
| Price to Cash Flow | 13.78 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|